SP1 and breast carcinoma: In breast cancer, miR-22 could indirectly inhibit CD147-associated tumor invasion and metastasis by repressing Sp1 expression, and form an auto-regulatory loop with Sp1 by binding to the miR-22 promoter to inhibit miR-22 transcription [19].